A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)

Julia Katharina Schwarze; Wietse Geens; Jens Tijtgat; Gil Awada; Laura Seynaeve; Anne-Marie Vanbinst; Hendrik Everaert; Alex Michotte; Michael Bruneau; Ivan Van Riet; Sandra Tuyaerts; Johnny Duerinck; Bart Neyns

A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)

Julia Katharina Schwarze, Wietse Geens, Jens Tijtgat, Gil Awada, Laura Seynaeve, Anne-Marie Vanbinst, Hendrik Everaert, Alex Michotte, Michael Bruneau, Ivan Van Riet, Sandra Tuyaerts, Johnny Duerinck, Bart Neyns

Onderzoeksoutput: Meeting abstract (Journal)

Originele taal-2	English
Artikelnummer	2033
Tijdschrift	Journal of Clinical Oncology
Volume	40
Nummer van het tijdschrift	16
Status	Published - 1 jun 2022
Evenement	Annual Meeting of the American-Society-of-Clinical-Oncology - virtual event, Chicago, United States Duur: 3 jun 2022 → 7 jun 2022

Toegang tot document

https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.2033Licentie: Unspecified

Citeer dit

Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Seynaeve, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Van Riet, I., Tuyaerts, S., Duerinck, J., & Neyns, B. (2022). A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB). Journal of Clinical Oncology, 40(16), [2033]. https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.2033

Schwarze, Julia Katharina ; Geens, Wietse ; Tijtgat, Jens ; Awada, Gil ; Seynaeve, Laura ; Vanbinst, Anne-Marie ; Everaert, Hendrik ; Michotte, Alex ; Bruneau, Michael ; Van Riet, Ivan ; Tuyaerts, Sandra ; Duerinck, Johnny ; Neyns, Bart. / A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB). In: Journal of Clinical Oncology. 2022 ; Vol. 40, Nr. 16.

@article{5cc4db29964d46cdb14e22915a740b93,

title = "A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)",

keywords = "phase I clinical trail, intracranial administration, myDC, ipilimumab, nivolumab, recurrent glioblastoma",

author = "Schwarze, {Julia Katharina} and Wietse Geens and Jens Tijtgat and Gil Awada and Laura Seynaeve and Anne-Marie Vanbinst and Hendrik Everaert and Alex Michotte and Michael Bruneau and {Van Riet}, Ivan and Sandra Tuyaerts and Johnny Duerinck and Bart Neyns",

year = "2022",

month = jun,

day = "1",

language = "English",

volume = "40",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

note = "Annual Meeting of the American-Society-of-Clinical-Oncology ; Conference date: 03-06-2022 Through 07-06-2022",

}

Schwarze, JK , Geens, W , Tijtgat, J , Awada, G , Seynaeve, L , Vanbinst, A-M , Everaert, H, Michotte, A, Bruneau, M , Van Riet, I , Tuyaerts, S , Duerinck, J & Neyns, B 2022, 'A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)', Journal of Clinical Oncology, vol. 40, nr. 16, 2033. <https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.2033>

A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB). / Schwarze, Julia Katharina ; Geens, Wietse ; Tijtgat, Jens ; Awada, Gil ; Seynaeve, Laura ; Vanbinst, Anne-Marie ; Everaert, Hendrik; Michotte, Alex; Bruneau, Michael ; Van Riet, Ivan ; Tuyaerts, Sandra ; Duerinck, Johnny ; Neyns, Bart.

In: Journal of Clinical Oncology, Vol. 40, Nr. 16, 2033, 01.06.2022.

Onderzoeksoutput: Meeting abstract (Journal)

TY - JOUR

T1 - A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)

AU - Schwarze, Julia Katharina

AU - Geens, Wietse

AU - Tijtgat, Jens

AU - Awada, Gil

AU - Seynaeve, Laura

AU - Vanbinst, Anne-Marie

AU - Everaert, Hendrik

AU - Michotte, Alex

AU - Bruneau, Michael

AU - Van Riet, Ivan

AU - Tuyaerts, Sandra

AU - Duerinck, Johnny

AU - Neyns, Bart

PY - 2022/6/1

Y1 - 2022/6/1

KW - phase I clinical trail

KW - intracranial administration

KW - myDC

KW - ipilimumab

KW - nivolumab

KW - recurrent glioblastoma

M3 - Meeting abstract (Journal)

VL - 40

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 16

M1 - 2033

T2 - Annual Meeting of the American-Society-of-Clinical-Oncology

Y2 - 3 June 2022 through 7 June 2022

ER -